Ligand exchange mechanism and enantioseparation
In the first and second techniques of LEC (described in the introduction section of this paper) the ligand is covalently or non-covalently linked to a solid support. This allows the linked chiral selector to form diastereomeric complexes with enantiomers. These complexes may have different stabilities, leading to the racemate separation. However, the addition of chiral dopant in the mobile phase makes the mechanism of chiral resolution complicated. In such a condition it may involve a series of complexation equilibriums in the mobile and in the stationary phases as well as partition equilibriums of the different species between the two phases (
21).
In the chromatographic separation using bidentate ligand selectors, the stereoselectivity in solution is much important than the different affinity of the diastereomeric complexes to the stationary phase (
23). However, in the case of tridentate ligands a different explanation for enantioseparation has been proposed (
21,
24)
Regardless of the most dominant factor involved in the separation task, the chiral ligand-exchange chromatography is based on the formation of diastereomeric ternary mixed metal complexes between the enantiomerically pure selector and the chiral isomers to be resolved. Therefore, the presence of certain functional groups, such as amino, hydroxy or carboxy groups on both selector and analyte is a prerequisite for a successful enantioseparation (
21).
In the case of PRN, two functional groups including hydroxy and amino groups are capable of creation coordination bonding with an appropriate metal ion. On the other hand, the selected chiral selector molecule (L-alanine) has also carboxylic acid and amine functional groups capable to interact with the same metal ion. Equation 1 and 2 show the proposed reactions resulting in different diastereomeric ternary mixed metal complexes.
Cu (L-alanine) 2 + (S)-PRN [Cu (L-alanine) ((S)-PRN)] + L-alanine (1)
Cu (L-alanine) 2 + (R)-PRN [Cu (L-alanine) ((R)-PRN)] + L-alanine (2)
In this study, we observed that the elution of racemic mixture of propranolol through a reversed phase column and using a mobile phase of water/methanol (70:30), doped with L-alanine and Cu (II), resulted in two separate chromatographic peaks. It was found that (R)-enantiomer was eluted before (S)-enantiomer. The peak identity was checked by injecting single (R) - and (S) - enatiomers.
As described above, when the chiral selector is continuously doped in the mobile phase, like this procedure, the main factor involved in the recognition mechanism has been substantiated to be the affinity of the formed diastereomeric complexes to the stationary phase. The diastereomeric complexes, formed here, can show different hydrophobic interaction capability outside the complex, depending on the complex structure. The schematic representation of the suggested diastereomeric complexes are illustrated in
Figure 1 The side chains of both L-alanine and (S)-PRN in the case of pseudo-homochiral complex are located in the same side in the space; whereas, the side chains of L-alanine and (R)-PRN in the case of pseudo-heterochiral complex are present in the opposite sides. This can lead to stronger hydrophobic interactions of the pseudo-homochiral complex with the apolar stationary phase (C
8 or C
18), resulting in longer retention time of (S)-PRN, compared to that of (R)-PRN. The described proposal was verified by replacement of chiral selectror by L-alanine with D-alanine in the mobile phase that led to the reversing of the retention order of (R)-and (S)- PRN in the column. The chromatograms depicted in
Figure 2 represent the effect of change in chiral selector kind (L-alanine to D-alanine) on the elution order of propranolol optical isomers.
The effect of copper salt type on the separation
The effect of the anion of the copper salt, loaded in the mobile phase, on the enantioseparation efficiency of the LEC method has been previously reported (
25-
27). Furthermore, the crucial effect of copper salt kind on the enantioseparation of atenolol was described in our previous work (
28). Therefore, in this work the effect of copper salt kind on the enantioseparation of propranolol by the developed method was investigated.
Figure 3 represents the effect of different copper salts including copper nitrate, copper sulfate, copper chloride and copper acetate on the chiral resolution of propranolol. It can be seen that using copper nitrate, copper sulfate, and copper chloride the optically active isomers of propranolol can be resolved acceptably; although, the peaks resolution in the case of copper nitrate is relatively better than the others. However, in the case of copper acetate, no appropriate enntioseparation is identified. Each cupric anion can act as the analyte competitor in the complexation process, revealing itself more or less influent in the overall chromatographic separation. The magnitude of the stated competition has also revealed to be strictly dependent on the physico-chemical properties of each individual analyte (
26). Among the examined copper salts anions, acetate anion can be considered as a powerful competitive ligand, capable of affecting the kinetic and thermodynamic of ternery diastereomeric complexes formation. We think that propranolol can not involve in the relevant diastereomeric complexes in the presence of acetate anions; because, this anion can actively participate in the complex formation, preventing thus the propranolol reaction with Cu
2+. In the presence of the other anions, however, propranolol can participate in the relevant diastereomeric complexes formation because of weak complexing power of these anions. At such a condition, the difference in hydrophobic interactions of two formed diastereomeric complexes with nonpolar stationary phase can lead to enantiomeric separation of propranolol (
28).
Chemical structure for the ternery diastereomeric complexes involving (R)-PRN and (S)-PRN (designed by molecular mechanics (MM2)); pseudo-homochiral complex (a), pseudo-heterochiral complex (b)
The effect of change in chiral selector kind (L-alanine to D-alanine) on the elution order of propranolol optical isomers; C8 column, mobile phase pH= 5, methanol/water (30:70), Flow rate= 0.4 mL.min.-.1
The effect of copper salt kind on the enantioseparation of propranolol by ligand-exchange chromatography: L-alanine as chiral selector, C8 column, mobile phase pH= 5, methanol/water (30:70), Flow rate= 0.4 mL min.-1
The chromatograms obtained for propranolol enantioseparation by using C8 (left) and C18 (right) columns; other separation conditions: copper nitrate as central complexing ion source, L-alanine as chiral selector, mobile phase pH=5, methanol/water (30:70) as mobile phase, Flow rate= 0.4 mL min
The effect of organic modifier (methanol) content of the mobile phase (I) and L-alanine/Cu2+ mole ratio (II) on the PRN enantioseparation; copper nitrate as central complexing ion source, L-alanine as chiral selector, C8 column, mobile phase pH= 5, Flow rate= 0.4 mL min.-1
Propranolol enantioseparation by the chiral ligand exchange HPLC method using different concentrations of L-alanine including: 0.5 mmol L-1 (a), 1.1 mmol L-1 (b), 2.2 mmol L-1 (c) and 3.4 mmol L-1(d); copper nitrate as central complexing ion source, C8 column, mobile phase pH= 5, methanol/water(30:70) as mobile phase, Flow rate= 0.4 mL.min-1
Enantioseparation of propranolol by the chiral ligand exchange HPLC method using various mobile phases pH including: 2.5 (a), 3.5 (b), 4.6 (c), 5.0 (d), 5.7 (e) and 6.7 (f); L-alanine as chiral selector, C8 column, Flow rate= 0.4 mL.min-1
Calibration curve obtained for the (R)-PRN (I) and (S)-PRN (II) at the optimized conditions
| ample | add (×102µg mL-1)
| found (×102 µg mL-1)
| recovery% ( n=4) |
|---|
| (S)-PRN | (R)-PRN | (S)-PRN | (R)-PRN | (S)-PRN | (R)-PRN |
|---|
| 1 | 12.0 | 12.0 | 12.5 | 12.3 | 104.2( ±5.4 ) | 102.5( ±6.5 ) |
| 2 | 5.5 | 5.5 | 5.2 | 5.1 | 94.5( ±6.4 ) | 92.7( ±5.9 ) |
| 3 | 15.0 | 5.0 | 14.6 | 4.7 | 97.3( ±5.9 ) | 94.0( ±5.7 ) |
| 4 | 34.0 | 5.0 | 35.5 | 5.4 | 105.0( ±6.1 ) | 104.4( ±5.1 ) |
The effect of column on the separation
The effect of stationary phase kind on the separation efficiency was examined by carrying out of propranolol enantioseparation via two different columns, packed with C
8 and C
18 stationary phases. The obtained results are demonstrated in
Figure. 4. As can be seen, the separation of PRN enantiomers by ligand-exchange chromatography technique in C
8 is better than that in C
18, regarding the peak resolution efficiency. It is clear that both peaks in C
18 column are broadened and the separation of two enantiomers is not satisfactory. These results indicate that the stationary phase type is a prominent factor in enatioseparation; although, both stationary phases are inherently achiral and provide the same interaction nature, when encountering the species to be eluted. As a probable proof for this observation, we think that in the case of C
18 phase, non-selective retention of the non-complexed PRN makes a noticeable contribution in the observed inappropriate separation process.
The effect of organic modifier and selector/Cu (II) mole ratio
It was found that the presence of organic solvent was crucially necessary for the enantioseparation of PRN; since, the separated peaks were highly broadened in the absence of organic solvent in the mobile phase. No appropriate resolutions were obtained by using acetonitrile and tetrahydrofurane. However, the addition of methanol, as an organic modifier, to the mobile phase resulted in reliable enantioseparation. Furthermore, the amount of methanol in the mobile phase was also found to be important, regarding the chiral separation efficiency.
Figure 5 (I) shows the effect of methanol percent in the mobile phase on the separation parameters including K′
R, K′
S and α. It can be seen that K′
S is influenced more intensively by the methanol amount changing, compared to K′
R. This is reasonable; since, the interaction of (S)-PRN involved ternary complex with the stationary phase is higher than that formed with (R)-PRN. This parameter increases firstly, as the methanol percent increases; but, after 30%, further increase in methanol amount gives rise to decrease in K′
S. Such a behavior can be observed in the case of K′
R; however, the dependence of the later parameter on the methanol amount is not considerable. The described figure indicates that the best separation can be obtained in methanol percent of 30%, regarding the α value which is maximum when the percent of methanol reaches to 30% in the mobile phase composition.
Figure 5 (II) shows that as the mole ratio of (L-alanine/Cu
2+) increases in the mobile phase, the selectivity coefficient sharply enhances till mole ratio of about 7 and after, the enantioselectivity changing as a function of (L-alanine/Cu
2+) mole ratio is not noticeable.
It was observed that other than the described mole ratio the amount of chiral selector, loaded in the mobile phase, was critically important in the efficiency of the chiral separation of propranolol.
Figure 6. Shows the effect of the concentration of L-alanine in the mobile phase on the enantioseparation performance. It must be noted that in this experiment the mole ratio of (L-alanine/Cu
2+) was fixed at the value of 7. It can be seen that this factor has an important role in the efficiency of the enantioseparation. It is evident that one need to an optimum amount of chiral selector for successful enantioseparation, namely, above and also below the optimum amount, the enantioseparation efficiency of the developed method is lost. The results depicted in Figure 6, suggest that using 1.1 mm of L-alanine in the mobile phase can lead to a satisfactory propranolol enantioseparation.
The effect of mobile phase pH
The dependence of propranolol enantioselectivity on the mobile phase pH was investigated by changing mobile phase pH in the range of 2.5-6.7.
Figure 7 show the chromatograms obtained by the developed chiral separation method at different mobile phase pH values. It is clear that the mobile phase pH has crucial effect on the enantiomers resolution. As can be observed, when the pH of mobile phase is adjusted to 2.5, 3.5 or even 4.6 no resolution is observed for PRN enantiomers. This may be because of suppression of the formation diastereomeric complexes at lower pH values. The enantioseparation of propranolol is achieved at pH of about 5. Further than pH of 5, the enantioseparation is still retained; but, it is not as proper as that at pH of 5. Therefore, in all separation experiments, executed in this work, the mobile phase pH was adjusted to about 5.
Validation of the method
In order to apply the developed enantioseparation method for quantitative analysis of propranolol enantiomers the calibration curves were constructed using the areas of the chromatographic peaks of both enantiomers, calculated at increasing concentrations. The results obtained are illustrated in
Figure.8 .Based on the depicted curves, the (S)-PRN and (R)-PRN can be determined at linear concentration ranges of 5-200 and 8-200 µg mL
-1, respectively. The limits of detections for (S)-PRN and (R)-PRN were found to be 2.0 and 1.1 µg mL
-1, respectively (signal-to-noise ratio of 3). The intra- and interday accuracy and precision of the assay, assessed as relative standard deviation (RSD), were determined by assaying the samples of PRN enantiomers at three different concentrations in four replicates in the same day and consecutive days. The results showed that the intraday relative standard deviations and interday relative standard deviations of the proposed method were 4.3% and 5.4% for (S)-PRN, and 3.3% and 5.4% for (R)-PRN, respectively.
The developed HPLC method was applied for the analysis of propranolol enantiomers in the spiked human blood plasma samples. The obtained results are summarized in
table 1. It must be noted that, before spiking of propranolol, the presence of any propranolol in the tested sample was checked by using the developed HPLC method and the absence of propranolol in aimed plasma samples was confirmed. It can be seen that the method leads to satisfactory results in propranolol enantiomers measurement in plasma samples, regarding recoveries and determination precision in all tested cases.